LINC02115

Across TCGA pan-cancer cohorts, LINC02115 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02115 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC02115 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02115 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

STAD, KIRC, and DLBC are the cancer types where LINC02115 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.426	0.725	<.001	133	view →
KIRC	DFS	Median	All	0.511	0.723	<.001	74	view →
DLBC	DFS	Tertile	II,III,IV	0.452	0.840	.007	57	view →
LUAD	OS	Quartile	All	0.321	0.467	.001	56	view →
HNSC	OS	Tertile	IV	0.546	0.292	.006	48	view →
BLCA	OS	Median	IV	0.698	0.505	.008	30	view →
ESCA	OS	Median	II,III,IV	0.400	0.608	.006	29	view →
SKCM	DFS	Median	II,III,IV	0.178	0.382	<.001	27	view →
ACC	OS	Quartile	III,IV	0.425	0.806	.001	24	view →
LIHC	OS	Median	III,IV	0.637	0.208	.001	20	view →
OV	OS	Quartile	II,III,IV	0.401	0.304	.021	16	view →
KIRP	DFS	Tertile	II,III,IV	0.864	0.260	.015	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02115–STAD (DFS)

Open the STAD breakdown →